HealthLawProf Blog

Editor: Katharine Van Tassel
Creighton University School of Law

Friday, August 19, 2005

Merck's Biggest Hit (So Far): $253 Million

In most law school curricula, there's a fairly clear divide between med mal and health law, a divide that is largely reflected in the membership of the ABA Health Law Section and the AHLA, as well as here at HealthLawBlog.  So today's jury verdict of $253 million for the plaintiff in the Vioxx trial in Angleton, TX (see Bloomberg's article on it) would be of only passing interest here except for one thing: what it tells us about Big Pharma in the early years of the 21st Century.  An early attempt to put the verdict in a larger context of drug safety and the regulatory environment is Katrina Vanden Heuvel's "editor's blog" over on The Nation's website[tm]

| Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference Merck's Biggest Hit (So Far): $253 Million: